Evidence map›Paper›PMID 30126990›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2018

Stunted childhood growth is associated with decompartmentalization of the gastrointestinal tract and overgrowth of oropharyngeal taxa.

Pascale Vonaesch, Evan Morien, Lova Andrianonimiadana, Hugues Sanke, Jean-Robert Mbecko, Kelsey E Huus, Tanteliniaina Naharimanananirina, Bolmbaye Privat Gondje, Synthia Nazita Nigatoloum, Sonia Sandrine Vondo and 12 more

Registry-linked trialOpen access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07451171 (A Phase II Trial to Prevent Linear Growth Stunting and Malnutrition in Impoverished Children From a Low-Income Country by Treating Small Intestine Bacterial Overgrowth), which is not on this map. Cited by 112 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 3 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07451171 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

A Phase II Trial to Prevent Linear Growth Stunting and Malnutrition in Impoverished Children From a Low-Income Country by Treating Small Intestine Bacterial Overgrowth

TypeinterventionalSponsorUniversity of VirginiaRan2026 to 2026Enrolled60ConditionsSmall Intestine Bacterial OvergrowthArmsTrimethoprim-sulfamethoxazole (TMP/SMX), Metronidazole, Amoxicillin-Clavulanate (4:1 formulation)
3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 3 syntheses or guidelines pooled it, 182 citations in OpenAlex.

  1. Pooled it
  2. Roles of the gut microbiome in weight management.Nature reviews. Microbiology · 2023
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. The gut microbiota in malnutrition.Nature reviews. Microbiology · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. One Health, One Microbiome.Microbiome · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 4 countries.

Pascale VonaeschUnité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France.
Evan MorienDepartment of Botany, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Lova AndrianonimiadanaUnité de Bactériologie Expérimentale, Institut Pasteur de Madagascar, BP 1274 Ambatofotsikely, 101 Antananarivo, Madagascar.
Hugues SankeLaboratoires d'Analyses Médicales, Institut Pasteur de Bangui, BP 923 Bangui, Central African Republic.
Jean-Robert MbeckoLaboratoires d'Analyses Médicales, Institut Pasteur de Bangui, BP 923 Bangui, Central African Republic.
Kelsey E HuusMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Tanteliniaina NaharimanananirinaCentre Hospitalier Universitaire Joseph Ravoahangy Andrianavalona, BP 4150, 101 Antananarivo, Madagascar.
Bolmbaye Privat GondjeComplexe Pédiatrique de Bangui, BP 923 Bangui, Central African Republic.
Synthia Nazita NigatoloumComplexe Pédiatrique de Bangui, BP 923 Bangui, Central African Republic.
Sonia Sandrine VondoComplexe Pédiatrique de Bangui, BP 923 Bangui, Central African Republic.
Jepthé Estimé Kaleb KandouUnité d'Epidémiologie, Institut Pasteur de Bangui, BP 923 Bangui, Central African Republic.
Rindra RandremananaUnité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, BP 1274 Ambatofotsikely, 101 Antananarivo, Madagascar.
Maheninasy RakotondrainipianaUnité d'Epidémiologie et de Recherche Clinique, Institut Pasteur de Madagascar, BP 1274 Ambatofotsikely, 101 Antananarivo, Madagascar.
Florent MazelDepartment of Botany, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Serge Ghislain DjorieUnité d'Epidémiologie, Institut Pasteur de Bangui, BP 923 Bangui, Central African Republic.
Jean-Chrysostome GodyComplexe Pédiatrique de Bangui, BP 923 Bangui, Central African Republic.
B Brett FinlayMichael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Pierre-Alain RubboLaboratoires d'Analyses Médicales, Institut Pasteur de Bangui, BP 923 Bangui, Central African Republic.
Laura Wegener ParfreyDepartment of Botany, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Jean-Marc CollardUnité de Bactériologie Expérimentale, Institut Pasteur de Madagascar, BP 1274 Ambatofotsikely, 101 Antananarivo, Madagascar.
Philippe J SansonettiUnité de Pathogénie Microbienne Moléculaire, Institut Pasteur, 75015 Paris, France; philippe.sansonetti@pasteur.fr.
Afribiota Investigators
Institut Pasteur de Bangui · CFInstitut Pasteur de Madagascar · MGUniversity of Bangui · CFUniversity of British Columbia · CAInserm · FR

Funding

CIHRHoward Hughes Medical Institute
6 · The paper itself

Abstract

Linear growth delay (stunting) affects roughly 155 million children under the age of 5 years worldwide. Treatment has been limited by a lack of understanding of the underlying pathophysiological mechanisms. Stunting is most likely associated with changes in the microbial community of the small intestine, a compartment vital for digestion and nutrient absorption. Efforts to better understand the pathophysiology have been hampered by difficulty of access to small intestinal fluids. Here, we describe the microbial community found in the upper gastrointestinal tract of stunted children aged 2-5 y living in sub-Saharan Africa. We studied 46 duodenal and 57 gastric samples from stunted children, as well as 404 fecal samples from stunted and nonstunted children living in Bangui, Central African Republic, and in Antananarivo, Madagascar, using 16S Illumina Amplicon sequencing and semiquantitative culture methods. The vast majority of the stunted children showed small intestinal bacterial overgrowth dominated by bacteria that normally reside in the oropharyngeal cavity. There was an overrepresentation of oral bacteria in fecal samples of stunted children, opening the way for developing noninvasive diagnostic markers. In addition,

Indexed as

CampylobacterChild DevelopmentClostridiumEscherichia coliGastrointestinal MicrobiomeGrowth DisordersIntestine, SmallShigellaChild, PreschoolFemaleHumansMaledecompartmentalizationmicrobiotaoropharyngeal taxastuntingsub-Saharan Africa

Identifiers

PMID30126990
PMCPMC6130352
OpenAlexW2888423719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.